StockData
CHENYSEServices-Home Health Care ServicesFiscal year ends December 31

CHEMED CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026
$508.29−4.09 (-0.80%)

Close on Oct 19, 2026

Market cap
$6.71B
P/E (TTM)
25.5
Dividend yield
0.43%

Earnings

Next report expected Oct 27, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Jul 28, 2026After market close$673.30M$5.13$6.06
Q1 FY2026
Ended Mar 31, 2026
Apr 23, 2026After market close$657.50M$4.84$5.65
Q4 FY2025
Ended Dec 31, 2025
Feb 25, 2026After market close$639.30M$5.48$6.42
Q3 FY2025
Ended Sep 30, 2025
Oct 28, 2025After market close$624.90M$4.46$5.27
Q2 FY2025
Ended Jun 30, 2025
Jul 29, 2025After market close$618.80M$3.57$4.27
Q1 FY2025
Ended Mar 31, 2025
Apr 23, 2025After market close$646.90M$4.86$5.63
Q4 FY2024
Ended Dec 31, 2024
Feb 26, 2025After market close$640.00M$6.02$6.83
Q3 FY2024
Ended Sep 30, 2024
Oct 29, 2024After market close$606.20M$5.00$5.64
Q2 FY2024
Ended Jun 30, 2024
Jul 24, 2024After market close–––
Q1 FY2024
Ended Mar 31, 2024
Apr 24, 2024After market close–––
Q4 FY2023
Ended Dec 31, 2023
Feb 27, 2024After market close–––

Company guidance

Outlook given with results on Jul 28, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
earnings per diluted share, excluding non-cash expenses for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete itemsnon-GAAPfull-year 2026$25.00 to $25.75Raised
adjusted EBITDA marginnon-GAAPfull year21.5% to 22.5%Lowered
anticipated revenue growthfull year3% to 3.5% growthMaintained

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Chemed filed with the SEC